skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Irritable bowel syndrome: diagnostic approaches in clinical practice

Review

(2347) Views  (766) Full article downloads

Authors: Eugene J Burbige

Published Date September 2010 Volume 2010:3 Pages 127 - 137
DOI: http://dx.doi.org/10.2147/CEG.S12596

Eugene J Burbige
Division of Gastroenterology, Gastrointestinal and Liver Research, John Muir Medical Center, Concord, CA, USA

Background: Irritable bowel syndrome (IBS), a functional gastrointestinal disorder long considered a diagnosis of exclusion, has chronic symptoms that vary over time and overlap with those of non-IBS disorders. Traditional symptom-based criteria effectively identify IBS patients but are not easily applied in clinical practice, leaving >40% of patients to experience symptoms up to 5 years before diagnosis.
Objective: To review the diagnostic evaluation of patients with suspected IBS, strengths and weaknesses of current methodologies, and newer diagnostic tools that can augment current symptom-based criteria.
Methods: The peer-reviewed literature (PubMed) was searched for primary reports and reviews using the limiters of date (1999–2009) and English language and the search terms irritable bowel syndrome, diagnosis, gastrointestinal disease, symptom-based criteria, outcome, serology, and fecal markers. Abstracts from Digestive Disease Week 2008–2009 and reference lists of identified articles were reviewed.
Results: A disconnect is apparent between practice guidelines and clinical practice. The American Gastroenterological Association and American College of Gastroenterology recommend diagnosing IBS in patients without alarm features of organic disease using symptom-based criteria (eg, Rome). However, physicians report confidence in a symptom-based diagnosis without further testing only up to 42% of the time; many order laboratory tests and perform sigmoidoscopies or colonoscopies despite good evidence showing no utility for this work-up in uncomplicated cases. In the absence of diagnostic criteria easily usable in a busy practice, newer diagnostic methods, such as stool-form examination, fecal inflammatory markers, and serum biomarkers, have been proposed as adjunctive tools to aid in an IBS diagnosis by increasing physicians’ confidence and changing the diagnostic paradigm to one of inclusion rather than exclusion.
Conclusion: New adjunctive testing for IBS can augment traditional symptom-based criteria, improving the speed and safety with which a patient is diagnosed and avoiding unnecessary, sometimes invasive, testing that adds little to the diagnostic process in suspected IBS.

Keywords: diagnosis, fecal markers, serum biomarkers, stool forms, symptom-based criteria






Readers of this article also read:

Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly
A review and empirical study of the composite scales of the Das–Naglieri cognitive assessment system
Molecular biocoding of insulin
Treating acid reflux disease in patients with Down syndrome: pharmacological and physiological approaches
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program
Enzyme replacement therapy for pancreatic insufficiency: present and future
Affective psychotherapy in post-traumatic reactions guided by affective neuroscience: memory reconsolidation and play
Update on the management of inflammatory bowel disease: specific role of adalimumab
Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances
Epidemiology and treatment of autoimmune hepatitis
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio